Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Misonix logo — company profile

Misonix

Founded 1955 United States Farmingdale, United States 59 employees Post Ipo Secondary Total: $55.00M Health Care, Manufacturing +2

General Information

Company Name Misonix
Founded Year 1955
Location United States Farmingdale, United States +1
Founders / Decision Makers
Team member
Employees 59
Industries Health Care, Manufacturing, Medical Devices +1
Funding Stage Post Ipo Secondary
Social

Get notified when Misonix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Misonix

Misonix, Inc. is a leading company in the health care and manufacturing industries, founded in 1955. The company's focus is on transforming patients' lives with innovative products that make a difference. Operating globally in over 45 countries, Misonix specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures. Its portfolio of products is based on the unique properties of ultrasound, offering unparalleled safety, speed, and precision. Misonix, Inc. recently received a $30.00MPost-IPO Secondary investment on 23 January 2020, which signifies a strong investor interest in the company's future prospects. While the specific investors behind this investment are not disclosed, the substantial investment reflects confidence in Misonix's potential for continued growth and success in the medical technology sector. The company's commitment to leveraging ultrasound technology for varied clinical needs positions it as a key player in the evolving surgical tools market. With a clear vision and a growing global presence, Misonix presents an intriguing opportunity for venture capital firms seeking to invest in innovative healthcare solutions. More information about Misonix, Inc. and its product portfolio can be found on the company's website at www.misonix.com.

Taxonomy: surgical technology, ultrasonic surgery, neurosurgery, spinal surgery, wound care, surgical instruments, laparoscopic surgery, precision surgery, tumor ablation, bone cutting technology, liposuction, HIFU systems, therapeutic ultrasound, global healthcare

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Secondary •••••• - 23 Jan 2020
Post-IPO Equity •••••• 2
Investor Investor
09 Nov 2017

Misonix Alternatives & Competitors

Misonix vs
Innoblative
Innoblative United States

Our core values are to drive innovation, improve patient experience, and impact economics.

Seed
11 employees
Design, Medical Devices
Compare Misonix vs Innoblative
Misonix vs
Orthoforge Inc.
Orthoforge Inc. United States

Bone and Soft Tissue Healing Analysis

Seed
2 employees
Health Care, Information Technology
Compare Misonix vs Orthoforge Inc.
Misonix vs
Imbed Biosciences Inc.
Imbed Biosciences Inc. United States

Advanced Materials for Soft Tissue Repair and Regeneration

Convertible Note
38 employees
Biotechnology, Health Care
Compare Misonix vs Imbed Biosciences Inc.

FAQ About Misonix

Transforming patients lives with better products that make a difference. Because better matters. Misonix, Inc. specializes in the development and commercialization of ultrasonic surgical devices for neurosurgical, spinal, advanced wound care, and general surgery procedures. Our portfolio of produ...
Misonix was founded in 1955.
Misonix is headquartered in Farmingdale, United States.
Misonix operates in the following industries: Health Care, Manufacturing, Medical Devices, Wellness Beauty.
Misonix has approximately 59 employees.
Misonix has completed 2 funding rounds, raising a total of $55.00M. The latest funding stage is Post Ipo Secondary.
Top alternatives and competitors to Misonix include Innoblative, Orthoforge Inc., Imbed Biosciences Inc., MBCP® Technology (Advanced Medical Solutions), ATS Medical, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Misonix and Innoblative are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Misonix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy